Cultural Integration in M&A

Most economists are predicting higher volumes for M&A over the next 12 months, albeit coming off a low base. In this article, Criticaleye’s Jacob Ambrose Willson hears from Matthew Parker, CEO of the highly acquisitive Babble, about the value of cultural integration in M&A.


Criticaleye supports senior leaders from a variety of businesses, sectors and geographies. With 83 percent of growth company executives in our research saying they are too inwardly focused, our global leadership Community provides a confidential and trusted space, offering diverse views which leaders can draw from when making decisions for themselves and their organisations. Click here to find out how we support growth company executives and non-executives.

 




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Talent-centered Design: A Blu...

In this report, Criticaleye’s CEO Retreat 2024 Partner Eightfold AI discusses the need for businesses to fundamentally rethink how they manage talent ahead of a massive skills-based shift. The report also argues t...

Click here to download this insight
Lean Operating Models Thought...

Traditional thinking on corporate operating models is evolving. In this report, Criticaleye’s Advisory Partners, AlixPartners, discusses how many companies are revaluating their operating models and driving greate...

Click here to download this insight
Riding the Growth Wave in Asi...

Speakers at Criticaleye's Asia Leadership Retreat discuss why Asia remains the engine of global growth despite a slowdown. Businesses need to navigate cost pressures, talent, leadership and the changing financial la...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,231




Concentrix LDC E.ON UK Mayborn Group Lightsource bp Eton Bridge Partners Robert Walters NATS AlixPartners Royal London Group Amazon UK Drax Group plc Veolia Water Technologies Tullow Oil plc Redwood Bank Eightfold AI Workday Google Salesforce Accenture GlaxoSmithKline plc London Stock Exchange Legal & General Investment Management Bunzl plc